Search for drugs:
Typing the drug name to query
GANCICLOVIR
DIR Classification
Classification:Less-DIR concern
Severity Score:1
Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF
- ADVERSE REACTIONS
- Postmarketing Experience
- The following adverse reactions have been identified during post-approval use of intravenous ganciclovir. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
- Blood and lymphatic system disorders: hemolytic anemia
- Cardiac disorders: cardiac arrest, cardiac conduction abnormality, torsades de pointes, ventricular tachycardia
Postmarketing Surveillance
Contingency Table:
Current Drug
Other Drugs
Rhabdomyolysis
4
42908
Other ADRs
983
14116296
Odds Ratio = 1.339
Drug Property Information
ATC Code(s):
- J05AB06 - ganciclovir
- J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors
- J05A - DIRECT ACTING ANTIVIRALS
- J05 - ANTIVIRALS FOR SYSTEMIC USE
- J - ANTIINFECTIVES FOR SYSTEMIC USE
- S01AD09 - ganciclovir
- S01AD - Antivirals
- S01A - ANTIINFECTIVES
- S01 - OPHTHALMOLOGICALS
- S - SENSORY ORGANS
Active Ingredient:ganciclovir
Active Ingredient UNII:P9G3CKZ4P5
Drugbank ID:DB01004
PubChem Compound:3454
CAS Number:82410-32-0
Dosage Form(s):capsule
Route(s) Of Administrator:oral
Daily Dose:
- 3000.0 mg/day J05AB06
Chemical Structure: 
SMILE Code:
C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
Reference
COHORT STUDY:
N/AOTHER REFERENCE(S):
1: Rhabdomyolysis associated with cytomegalovirus infection in kidney transplant recipients.
[Jung H-Y,Kim K-H,Park S-C,Lee J-H,Choi J-Y,Cho J-H,Park S-H,Kim Y-L,Kim H-K,Huh S,Kim C-D]Transpl Infect Dis.2014 Dec;16(6):993-8. doi: 10.1111/tid.12297. Epub 2014 Sep 24. PMID: 25251070
2: Acute rhabdomyolysis and myonecrosis complicating aeromonas bacteremia in neutropenic patients with hematologic malignancies: report of two cases.
[Martino R,Santamaría A,Pericas R,Sureda A,Brunet S]Haematologica.1997 Nov-Dec;82(6):692-4. PMID: 9499669
Disclaimer:
The content of this database of rhabdomyolysis is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.
The views presented in this website do not necessarily reflect current or future opinion or policy of the US Food and Drug Administration. Any mention of commercial products is for clarification and not intended as endorsement.